Literature DB >> 9513950

Review, reevaluation, and new results in quantitative structure-activity studies of anticonvulsants.

D Hadjipavlou-Litina1.   

Abstract

This paper reviews and reevaluates all of the published QSAR treatments of anticonvulsants and extends them to a new relationship. This reveals that in almost all cases, the Clog P relationship plays a significant part in the QSAR relationship whether the data stems from receptor to whole animal studies. In some cases the steric factors (B5, B1, and L) are important and, in one case, the log VW relationship is of marginal importance. Electronic effects, except for the Hammett's constant sigma, are comparatively unimportant. This suggests that the receptors involved possess a special stereochemical and electronic feature: The aromatic ring and the nitrogen moieties (e.g., an amide group) are the primary binding groups. The study shows that log P, as calculated by the Clog P program, is suitable for this form of QSAR study. Log Po of 2 was found to be ideal for passive penetration of these agents into the CNS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9513950     DOI: 10.1002/(sici)1098-1128(199803)18:2<91::aid-med1>3.0.co;2-m

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  3 in total

1.  QSAR modeling of AT1 receptor antagonists using ANN.

Authors:  Qing Su; Lu Zhou
Journal:  J Mol Model       Date:  2006-03-16       Impact factor: 1.810

2.  Reduced density gradient as a novel approach for estimating QSAR descriptors, and its application to 1, 4-dihydropyridine derivatives with potential antihypertensive effects.

Authors:  Christiaan Jardínez; Alberto Vela; Julián Cruz-Borbolla; Rodrigo J Alvarez-Mendez; José G Alvarado-Rodríguez
Journal:  J Mol Model       Date:  2016-11-26       Impact factor: 1.810

3.  Synthesis and anticonvulsant activity of new N-phenyl-2-(4-phenylpiperazin-1-yl)acetamide derivatives.

Authors:  Krzysztof Kamiński; Beata Wiklik; Jolanta Obniska
Journal:  Med Chem Res       Date:  2015-03-10       Impact factor: 1.965

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.